CN Stock MarketDetailed Quotes

688621 Beijing Sun-Novo Pharmaceutical Research

Watchlist
  • 31.42
  • +0.92+3.02%
Market Closed Aug 29 15:00 CST
3.52BMarket Cap16.34P/E (TTM)

Beijing Sun-Novo Pharmaceutical Research Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
22.08%562.86M
8.53%252.26M
37.76%932.12M
39.73%692M
42.16%461.05M
57.09%232.43M
37.06%676.61M
45.19%495.24M
44.71%324.31M
54.49%147.96M
Operating revenue
22.08%562.86M
8.53%252.26M
37.76%932.12M
39.73%692M
42.16%461.05M
57.09%232.43M
37.06%676.61M
45.19%495.24M
44.71%324.31M
54.49%147.96M
Total operating cost
22.52%388.53M
0.68%172.41M
35.63%686.94M
37.45%485.4M
40.68%317.12M
58.75%171.24M
38.22%506.49M
48.12%353.14M
48.87%225.41M
57.08%107.87M
Operating cost
24.75%247.73M
-13.50%101.97M
34.08%403.77M
42.38%303.83M
47.08%198.59M
83.54%117.88M
30.95%301.15M
43.55%213.39M
35.85%135.02M
47.44%64.22M
Operating tax surcharges
36.27%617.62K
189.70%338.54K
11.84%1.25M
2.79%863.09K
-18.84%453.25K
-65.75%116.86K
122.41%1.12M
107.65%839.7K
229.09%558.44K
248.79%341.24K
Operating expense
47.37%17.45M
29.22%8.51M
116.01%43.79M
34.95%19.4M
19.81%11.84M
25.20%6.59M
19.04%20.27M
25.18%14.38M
43.34%9.88M
51.26%5.26M
Administration expense
-3.60%48.92M
-7.21%24.66M
20.88%109.45M
14.60%74.81M
20.95%50.75M
32.67%26.58M
31.99%90.54M
59.28%65.28M
73.00%41.96M
71.16%20.03M
Financial expense
121.88%4.71M
160.75%1.96M
33.92%5M
31.46%3.36M
14.24%2.12M
-38.26%751.62K
34.75%3.73M
110.90%2.56M
99.76%1.86M
594.41%1.22M
-Interest expense (Financial expense)
59.87%8.35M
76.29%4.13M
25.55%12.18M
14.89%8.25M
12.82%5.22M
61.95%2.34M
172.10%9.7M
316.64%7.18M
337.39%4.63M
474.44%1.45M
-Interest Income (Financial expense)
-17.14%-3.67M
-35.76%-2.18M
-17.69%-7.24M
-5.91%-4.93M
-12.06%-3.13M
-61.77%-1.61M
-630.90%-6.15M
-719.59%-4.66M
-1,670.04%-2.79M
-935.70%-994.25K
Research and development
29.48%69.09M
80.85%34.97M
37.91%123.68M
46.61%83.13M
47.71%53.36M
15.14%19.33M
88.51%89.69M
58.92%56.7M
82.69%36.13M
73.91%16.79M
Credit Impairment Loss
-33.01%-26.91M
-28.12%-13.08M
-209.52%-60.18M
-102.62%-28.94M
-143.97%-20.23M
-142.07%-10.21M
-74.55%-19.44M
-102.05%-14.28M
-37.46%-8.29M
-28.24%-4.22M
Other net revenue
Invest income
-27.48%232.92K
-0.04%159.25K
-50.80%1.29M
-81.05%480.43K
-87.13%321.18K
-90.44%159.31K
55.93%2.62M
346.87%2.53M
624.75%2.5M
1,195.33%1.67M
Asset deal income
----
----
----
----
----
----
-2,554.54%-36.82K
257.16%5.61K
----
----
Other revenue
91.35%8.69M
462.24%7.5M
-50.89%7.87M
-34.37%5.32M
-3.57%4.54M
32.96%1.33M
230.97%16.02M
122.76%8.1M
34.18%4.71M
24.12%1M
Operating profit
21.62%156.34M
41.85%74.43M
14.70%194.16M
32.51%183.47M
31.44%128.56M
36.14%52.47M
38.08%169.27M
38.71%138.46M
38.70%97.81M
55.72%38.54M
Add:Non operating Income
-61.07%2K
75.70%2K
-89.49%10.08K
4.46%8.63K
-17.87%5.14K
-99.14%1.14K
88.80%95.87K
-25.21%8.26K
-32.30%6.26K
--132K
Less:Non operating expense
2,173.89%1.53M
134.19%122.8K
233.66%774.6K
167.15%499.9K
1,722.63%67.21K
6,976.76%52.44K
-57.06%232.15K
-22.47%187.12K
-98.46%3.69K
-91.35%740.96
Total profit
20.49%154.82M
41.76%74.31M
14.34%193.4M
32.32%182.98M
31.37%128.49M
35.55%52.42M
38.52%169.14M
38.85%138.28M
39.16%97.81M
56.31%38.67M
Less:Income tax cost
46.65%13.47M
23.13%5.57M
0.65%10.5M
30.36%10.33M
-14.60%9.19M
17.91%4.52M
-21.60%10.43M
-37.31%7.92M
7.81%10.76M
10.65%3.84M
Net profit
18.47%141.35M
43.52%68.74M
15.24%182.9M
32.44%172.65M
37.05%119.31M
37.49%47.9M
45.88%158.7M
49.92%130.36M
44.35%87.06M
63.75%34.84M
Net profit from continuing operation
18.47%141.35M
43.52%68.74M
15.24%182.9M
32.44%172.65M
37.05%119.31M
37.49%47.9M
45.88%158.7M
49.92%130.36M
44.35%87.06M
63.75%34.84M
Less:Minority Profit
-649.40%-7.22M
-10,351.48%-4.01M
-183.48%-1.86M
8.28%1.57M
503.24%1.31M
-102.67%-38.38K
-28.71%2.23M
-20.09%1.45M
-124.22%-326.06K
94.14%1.44M
Net profit of parent company owners
25.91%148.57M
51.77%72.75M
18.08%184.76M
32.72%171.08M
35.03%117.99M
43.52%47.94M
48.09%156.47M
51.42%128.9M
48.19%87.38M
62.65%33.4M
Earning per share
Basic earning per share
26.67%1.33
51.16%0.65
17.86%1.65
33.04%1.53
34.62%1.05
2.38%0.43
-7.28%1.4
-19.01%1.15
-20.41%0.78
23.53%0.42
Diluted earning per share
26.67%1.33
51.16%0.65
17.86%1.65
33.04%1.53
34.62%1.05
2.38%0.43
-7.28%1.4
-19.01%1.15
-20.41%0.78
23.53%0.42
Other composite income
Total composite income
18.47%141.35M
43.52%68.74M
15.24%182.9M
32.44%172.65M
37.05%119.31M
37.49%47.9M
45.88%158.7M
49.92%130.36M
44.35%87.06M
63.75%34.84M
Total composite income of parent company owners
25.91%148.57M
51.77%72.75M
18.08%184.76M
32.72%171.08M
35.03%117.99M
43.52%47.94M
48.09%156.47M
51.42%128.9M
48.19%87.38M
62.65%33.4M
Total composite income of minority owners
-649.40%-7.22M
-10,351.48%-4.01M
-183.48%-1.86M
8.28%1.57M
503.24%1.31M
-102.67%-38.38K
-28.71%2.23M
-20.09%1.45M
-124.22%-326.06K
94.14%1.44M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 22.08%562.86M8.53%252.26M37.76%932.12M39.73%692M42.16%461.05M57.09%232.43M37.06%676.61M45.19%495.24M44.71%324.31M54.49%147.96M
Operating revenue 22.08%562.86M8.53%252.26M37.76%932.12M39.73%692M42.16%461.05M57.09%232.43M37.06%676.61M45.19%495.24M44.71%324.31M54.49%147.96M
Total operating cost 22.52%388.53M0.68%172.41M35.63%686.94M37.45%485.4M40.68%317.12M58.75%171.24M38.22%506.49M48.12%353.14M48.87%225.41M57.08%107.87M
Operating cost 24.75%247.73M-13.50%101.97M34.08%403.77M42.38%303.83M47.08%198.59M83.54%117.88M30.95%301.15M43.55%213.39M35.85%135.02M47.44%64.22M
Operating tax surcharges 36.27%617.62K189.70%338.54K11.84%1.25M2.79%863.09K-18.84%453.25K-65.75%116.86K122.41%1.12M107.65%839.7K229.09%558.44K248.79%341.24K
Operating expense 47.37%17.45M29.22%8.51M116.01%43.79M34.95%19.4M19.81%11.84M25.20%6.59M19.04%20.27M25.18%14.38M43.34%9.88M51.26%5.26M
Administration expense -3.60%48.92M-7.21%24.66M20.88%109.45M14.60%74.81M20.95%50.75M32.67%26.58M31.99%90.54M59.28%65.28M73.00%41.96M71.16%20.03M
Financial expense 121.88%4.71M160.75%1.96M33.92%5M31.46%3.36M14.24%2.12M-38.26%751.62K34.75%3.73M110.90%2.56M99.76%1.86M594.41%1.22M
-Interest expense (Financial expense) 59.87%8.35M76.29%4.13M25.55%12.18M14.89%8.25M12.82%5.22M61.95%2.34M172.10%9.7M316.64%7.18M337.39%4.63M474.44%1.45M
-Interest Income (Financial expense) -17.14%-3.67M-35.76%-2.18M-17.69%-7.24M-5.91%-4.93M-12.06%-3.13M-61.77%-1.61M-630.90%-6.15M-719.59%-4.66M-1,670.04%-2.79M-935.70%-994.25K
Research and development 29.48%69.09M80.85%34.97M37.91%123.68M46.61%83.13M47.71%53.36M15.14%19.33M88.51%89.69M58.92%56.7M82.69%36.13M73.91%16.79M
Credit Impairment Loss -33.01%-26.91M-28.12%-13.08M-209.52%-60.18M-102.62%-28.94M-143.97%-20.23M-142.07%-10.21M-74.55%-19.44M-102.05%-14.28M-37.46%-8.29M-28.24%-4.22M
Other net revenue
Invest income -27.48%232.92K-0.04%159.25K-50.80%1.29M-81.05%480.43K-87.13%321.18K-90.44%159.31K55.93%2.62M346.87%2.53M624.75%2.5M1,195.33%1.67M
Asset deal income -------------------------2,554.54%-36.82K257.16%5.61K--------
Other revenue 91.35%8.69M462.24%7.5M-50.89%7.87M-34.37%5.32M-3.57%4.54M32.96%1.33M230.97%16.02M122.76%8.1M34.18%4.71M24.12%1M
Operating profit 21.62%156.34M41.85%74.43M14.70%194.16M32.51%183.47M31.44%128.56M36.14%52.47M38.08%169.27M38.71%138.46M38.70%97.81M55.72%38.54M
Add:Non operating Income -61.07%2K75.70%2K-89.49%10.08K4.46%8.63K-17.87%5.14K-99.14%1.14K88.80%95.87K-25.21%8.26K-32.30%6.26K--132K
Less:Non operating expense 2,173.89%1.53M134.19%122.8K233.66%774.6K167.15%499.9K1,722.63%67.21K6,976.76%52.44K-57.06%232.15K-22.47%187.12K-98.46%3.69K-91.35%740.96
Total profit 20.49%154.82M41.76%74.31M14.34%193.4M32.32%182.98M31.37%128.49M35.55%52.42M38.52%169.14M38.85%138.28M39.16%97.81M56.31%38.67M
Less:Income tax cost 46.65%13.47M23.13%5.57M0.65%10.5M30.36%10.33M-14.60%9.19M17.91%4.52M-21.60%10.43M-37.31%7.92M7.81%10.76M10.65%3.84M
Net profit 18.47%141.35M43.52%68.74M15.24%182.9M32.44%172.65M37.05%119.31M37.49%47.9M45.88%158.7M49.92%130.36M44.35%87.06M63.75%34.84M
Net profit from continuing operation 18.47%141.35M43.52%68.74M15.24%182.9M32.44%172.65M37.05%119.31M37.49%47.9M45.88%158.7M49.92%130.36M44.35%87.06M63.75%34.84M
Less:Minority Profit -649.40%-7.22M-10,351.48%-4.01M-183.48%-1.86M8.28%1.57M503.24%1.31M-102.67%-38.38K-28.71%2.23M-20.09%1.45M-124.22%-326.06K94.14%1.44M
Net profit of parent company owners 25.91%148.57M51.77%72.75M18.08%184.76M32.72%171.08M35.03%117.99M43.52%47.94M48.09%156.47M51.42%128.9M48.19%87.38M62.65%33.4M
Earning per share
Basic earning per share 26.67%1.3351.16%0.6517.86%1.6533.04%1.5334.62%1.052.38%0.43-7.28%1.4-19.01%1.15-20.41%0.7823.53%0.42
Diluted earning per share 26.67%1.3351.16%0.6517.86%1.6533.04%1.5334.62%1.052.38%0.43-7.28%1.4-19.01%1.15-20.41%0.7823.53%0.42
Other composite income
Total composite income 18.47%141.35M43.52%68.74M15.24%182.9M32.44%172.65M37.05%119.31M37.49%47.9M45.88%158.7M49.92%130.36M44.35%87.06M63.75%34.84M
Total composite income of parent company owners 25.91%148.57M51.77%72.75M18.08%184.76M32.72%171.08M35.03%117.99M43.52%47.94M48.09%156.47M51.42%128.9M48.19%87.38M62.65%33.4M
Total composite income of minority owners -649.40%-7.22M-10,351.48%-4.01M-183.48%-1.86M8.28%1.57M503.24%1.31M-102.67%-38.38K-28.71%2.23M-20.09%1.45M-124.22%-326.06K94.14%1.44M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Dahua Certified Public Accountants (Special General Partnership)------Dahua Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg